SUBSCRIBE
SUBSCRIBE

Indications

PRESS RELEASES
Press Releases
Eisai Deepens Body of Clinical Evidence for LENVIMA (Lenvatinib) Across Established Indications at ASCO 2026
May 20, 2026
 · 
26 min read
Press Releases
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
May 18, 2026
 · 
8 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer
May 17, 2026
 · 
19 min read
Press Releases
Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
May 17, 2026
 · 
19 min read
Press Releases
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
May 14, 2026
 · 
6 min read
Press Releases
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
May 13, 2026
 · 
16 min read
Press Releases
CardioPharma Reviews Applications to Explore Non-Cardiovascular Benefits of CVD Polypill
May 12, 2026
 · 
4 min read
Press Releases
FDA Advances Drug Repurposing to Address Unmet Medical Needs
May 11, 2026
 · 
3 min read
Press Releases
Avenacy Announces Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection in the U.S. Market
May 11, 2026
 · 
2 min read
Press Releases
LIB Therapeutics Launches LEROCHOL® (lerodalcibep-liga) in the United States with a Patient-First Approach to Access and Affordability
May 11, 2026
 · 
6 min read
Press Releases
Innovent Announces IBI363 (PD-1/IL-2α-bias Bispecific Fusion Protein) Received Third NMPA Breakthrough Therapy Designation for MSS/pMMR Metastatic Colorectal Cancer
May 11, 2026
 · 
5 min read
Press Releases
MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results
May 10, 2026
 · 
25 min read
Press Releases
World’s First | Mabwell’s 9MW5211 Receives FDA Clearance for Clinical Trial Application
May 10, 2026
 · 
5 min read
Press Releases
China Innovative Drug NHWD-870 Receives Breakthrough Therapy Designation, Bringing New Hope of Survival to NUT Carcinoma Patients
May 10, 2026
 · 
4 min read
Press Releases
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
May 10, 2026
 · 
5 min read
Press Releases
Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications
May 7, 2026
 · 
12 min read
Press Releases
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May 6, 2026
 · 
10 min read
Press Releases
LBL-047 Prioritized for Clinical Development in Sjögren’s Disease, Systemic Lupus Erythematosus, and Dermatomyositis
May 6, 2026
 · 
3 min read
Press Releases
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
May 4, 2026
 · 
7 min read
Press Releases
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
May 1, 2026
 · 
9 min read
Load More